Two leading medical stocks that appear reasonable at current levels are AbbVie (NYSE: ABBV) and Merck (NYSE: MRK). The former ...
The students were able to uncover a molecular structural discrepancy more than a decade ago, clearing a path for development ...
Portfolio manager highlights AbbVie, Pfizer and Medtronic as compelling large-cap health care dividend plays with growth and ...
Detailed price information for Astrazeneca Plc ADR (AZN-Q) from The Globe and Mail including charting and trades.
With the other premium services, you can dive deep into additional metrics, portfolios, commentary and information about ...
PsiThera, formerly Psivant Therapeutics, raised just over $47 million for oral drugs targeting “diseases long-constrained by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results